1. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial. Issue 4 (April 2018) Authors: De Placido, Sabino; Gallo, Ciro; De Laurentiis, Michelino; Bisagni, Giancarlo; Arpino, Grazia; Sarobba, Maria Giuseppa; Riccardi, Ferdinando; Russo, Antonio; Del Mastro, Lucia; Cogoni, Alessio Aligi; Cognetti, Francesco; Gori, Stefania; Foglietta, Jennifer; Frassoldati, Antonio; Amoroso, Domenico... Journal: Lancet oncology Issue: Volume 19:Issue 4(2018) Page Start: 474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Everolimus plus aromatase inhibitors as maintenance therapy after first-line chemotherapy: Final results of the phase III randomised MAIN-A (MAINtenance Afinitor) trial. (September 2021) Authors: Guarneri, Valentina; Giorgi, Carlo Alberto; Cinieri, Saverio; Bengala, Carmelo; Mariani, Gabriella; Bisagni, Giancarlo; Frassoldati, Antonio; Zamagni, Claudio; De Rossi, Costanza; Amoroso, Vito; Andreetta, Claudia; Ferro, Antonella; Zambelli, Alberto; Gori, Stefania; Garrone, Ornella; Dieci, Mari... Journal: European journal of cancer Issue: Volume 154(2021) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial. Issue 10 (October 2021) Authors: Del Mastro, Lucia; Mansutti, Mauro; Bisagni, Giancarlo; Ponzone, Riccardo; Durando, Antonio; Amaducci, Laura; Campadelli, Enrico; Cognetti, Francesco; Frassoldati, Antonio; Michelotti, Andrea; Mura, Silvia; Urracci, Ylenia; Sanna, Giovanni; Gori, Stefania; De Placido, Sabino; Garrone, Ornella; Fa... Journal: Lancet oncology Issue: Volume 22:Issue 10(2021) Page Start: 1458 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗